Jane Street’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-188,400
Closed -$3.15M 10490
2022
Q4
$3.15M Sell
188,400
-165,700
-47% -$2.8M ﹤0.01% 3144
2022
Q3
$6.07M Buy
354,100
+83,300
+31% +$1.31M ﹤0.01% 2314
2022
Q2
$2.12M Buy
270,800
+137,200
+103% +$1.18M ﹤0.01% 4055
2022
Q1
$1.48M Sell
133,600
-120,600
-47% -$1.35M ﹤0.01% 5330
2021
Q4
$4.47M Sell
254,200
-34,600
-12% -$671K ﹤0.01% 3039
2021
Q3
$5.85M Buy
288,800
+50,000
+21% +$1.29M ﹤0.01% 2498
2021
Q2
$7.89M Buy
238,800
+61,700
+35% +$2.33M ﹤0.01% 1997
2021
Q1
$6.92M Buy
177,100
+85,700
+94% +$4.02M ﹤0.01% 1964
2020
Q4
$3.99M Sell
91,400
-20,900
-19% -$714K ﹤0.01% 2413
2020
Q3
$3.19M Buy
112,300
+22,900
+26% +$723K ﹤0.01% 2368
2020
Q2
$3.25M Buy
+89,400
New +$2.52M ﹤0.01% 2397

Jane Street's ONEM Position: Q1 2023 in Review

Jane Street sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 173,080 shares — an estimated $2.89M sold.

Jane Street first reported a position in ONEM in Q2 2020 and held it in 11 quarters. The position peaked at $4.02M in Q2 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Jane Street reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 173,080 1Life Healthcare shares in Q1 2023, an estimated $2.89M.
  • Jane Street first reported a position in 1Life Healthcare in Q2 2020 and held it in 11 quarters.
  • Jane Street's 1Life Healthcare position peaked at $4.02M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.